semaglutide glp 1 receptor agonist GLP-1 Agonists as Treatments for Type 2 Diabetes Dual and Triple Gut Peptide
Description
Yue W, Li Y, Ou D, Yang Q
Smoking and hypertension as predictors of cardiovascular risk in population studies
Available from: Desprs JP, Carpentier AC, Tchernof A, Neeland IJ, Poirier P
doi:10.1007/s40262-018-0668-z 20
4 In this analysis, meta-regression showed no significant association between BP reduction and mean baseline age or the proportion of male participants
This article will review the formulation of oral semaglutide that allows for oral administration, discuss recently published efficacy and safety data, and consider the potential role of this novel GLP-1 receptor agonist in patient care
